Key Insights

Highlights

Success Rate

90% trial completion (above average)

Published Results

45 trials with published results (12%)

Research Maturity

197 completed trials (53% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.7%

21 terminated out of 369 trials

Success Rate

90.4%

+3.9% vs benchmark

Late-Stage Pipeline

22%

81 trials in Phase 3/4

Results Transparency

23%

45 of 197 completed with results

Key Signals

45 with results90% success21 terminated

Data Visualizations

Phase Distribution

234Total
Not Applicable (103)
Early P 1 (1)
P 1 (13)
P 2 (36)
P 3 (32)
P 4 (49)

Trial Status

Completed197
Unknown71
Recruiting42
Terminated21
Not Yet Recruiting17
Active Not Recruiting9

Trial Success Rate

90.4%

Benchmark: 86.5%

Based on 197 completed trials

Clinical Trials (369)

Showing 20 of 20 trials
NCT07572305Not ApplicableCompletedPrimary

Effects of Virtual Reality After Liver Transplantation

NCT07570901Completed

Impact of Delta Model of End Stage Liver Disease (MELD) in High MELD Liver Transplant Recipients

NCT05080595Not ApplicableCompletedPrimary

Transportation Assistance Program for Liver Transplant

NCT07547020Not Yet RecruitingPrimary

Hemodynamic Profiles and Macro-Microcirculatory Coherence in Liver Transplantation: an Integrative Approach in the Immediate Postoperative Period

NCT07561138Not ApplicableRecruiting

Nutrition and Exercise Prehabilitation in Patients Awaiting Liver Transplantation

NCT07304466Not ApplicableRecruitingPrimary

Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver Transplantation

NCT06916325Not ApplicableNot Yet Recruiting

Open Label Trial of Deceased Donor Livers Transplanted After DHOPE With eXVIVO LIVER Perfusion

NCT05237583Not ApplicableCompleted

Prehabilitation for Patients Awaiting Liver Transplantation

NCT06874296Not ApplicableRecruitingPrimary

Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting Time

NCT07530913Not ApplicableEnrolling By InvitationPrimary

Effectiveness Analysis of a Rehabilitation Exercise Platform for Living Donor Liver Transplantation Patients

NCT07519057Not ApplicableNot Yet RecruitingPrimary

Effect of Preoperative Oral Carbohydrate Loading on Postoperative Outcomes in Liver Transplant Patients

NCT07089589Completed

Preoperative Statin Use and Major Adverse Cardiovascular Events in Liver Transplant Recipients

NCT07506642Completed

Patient Reported Outcomes In Liver Biopsy (EUS vs. Percutaneous)

NCT06909942Not ApplicableCompleted

Association of Sarcopenia With Rocuronium Use in Liver Transplant Recipients

NCT06354179Phase 4RecruitingPrimary

Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)

NCT07468812CompletedPrimary

Physical Activity and Fatigue in Caregivers Before and After Liver Transplantation

NCT07269041Phase 1RecruitingPrimary

Immune Tolerance Induction After Liver Transplantation

NCT03820271Not ApplicableCompleted

New Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplantation

NCT07442214Active Not Recruiting

View of Cerebral Perfusion in Liver Transplantation

NCT07417423Not ApplicableCompletedPrimary

Home-Based Exercise Education in Liver Transplant Recipients

Scroll to load more

Research Network

Activity Timeline